Calcium sensors in kidneys may help combat hypoparathyroidism (EurekAlert, 13 August 2012)

ESPE Visiting Scholarship - next deadline - 31 October 2012

Vandetanib almost doubles progression free survival in patients with thyroid cancer (Medical Xpress, 13 August 2012)

14 Aug 2012

A European phase II trial published in The Lancet Oncology examines Vandetanib vs. placebo in patients with advanced differentiated thyroid cancer.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read